Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer (vol 76, pg 2301, 2016)

被引：0
|
作者：
Herrera-Abreu, Maria Teresa
Palafox, Marta
Asghar, Uzma
Rivas, Martin A.
Cutts, Rosalind J.
Garcia-Murillas, Isaac
Pearson, Alex
Guzman, Marta
Rodriguez, Olga
Grueso, Judit
Bellet, Meritxell
Cortes, Javier
Elliott, Richard
Pancholi, Sunil
Lord, Christopher J. [1 ,2 ]
Baselga, Jose
Dowsett, Mitch
Martin, Lesley-Ann
Turner, Nicholas C.
Serra, Violeta
机构：
[1] Inst Canc Res, CRUK Gene Funct Lab, London, England
[2] Inst Canc Res, Breast Canc Now Res Ctr, London, England
来源：
CANCER RESEARCH | 2016年 / 76卷 / 19期
关键词：
D O I：
10.1158/0008-5472.CAN-16-1853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5907 / 5907
页数：1
相关论文
共 50 条
  • [31] Influence of CDK4/6 inhibitors on the peripheral immune response in hormone receptor-positive breast cancer
    Peuker, C. A.
    Yaghobramzi, S.
    Grunert, C.
    Keilholz, L.
    Hennig, S.
    Schaper, S.
    Brucker, S.
    Decker, T.
    Fasching, P.
    Fehm, T.
    Janni, W.
    Kuemmel, S.
    Schneeweiss, A.
    Schuler, M.
    Lueftner, D.
    Busse, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 159 - 159
  • [32] Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
    Whittle, James R.
    Vaillant, Francois
    Surgenor, Elliot
    Policheni, Antonia N.
    Giner, Goknur
    Capaldo, Bianca D.
    Chen, Huei-Rong
    Liu, He K.
    Dekkers, Johanna F.
    Sachs, Norman
    Clevers, Hans
    Fellowes, Andrew
    Green, Thomas
    Xu, Huiling
    Fox, Stephen B.
    Herold, Marco J.
    Smyth, Gordon K.
    Gray, Daniel H. D.
    Visvader, Jane E.
    Lindeman, Geoffrey J.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 4120 - 4134
  • [33] Differential metabolic response of triple-negative and estrogen receptor-positive breast cancer cells to abemaciclib, a CDK4/6 inhibitor
    Jiang, Jun
    Bao, Xun
    Jiang, Yuanyuan
    Yue, Yang
    Huettemann, Maik
    Li, Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [34] STAT3 as a therapeutic target in estrogen receptor positive breast cancer patients refractory to CDK4/6 inhibition
    Kettner, Nicole M.
    Bui, Tuyen
    Ha, Min Jin
    Eckols, T. Kris
    Tweardy, David J.
    Meric-Bernstam, Funda
    Hunt, Kelly K.
    Tripathy, Debu
    Keyomarsi, Khandan
    CANCER RESEARCH, 2020, 80 (04)
  • [35] Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All
    Li, Jianbin
    CANCERS, 2025, 17 (04)
  • [36] Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
    Jennifer Y. Ge
    Shaokun Shu
    Mijung Kwon
    Bojana Jovanović
    Katherine Murphy
    Anushree Gulvady
    Anne Fassl
    Anne Trinh
    Yanan Kuang
    Grace A. Heavey
    Adrienne Luoma
    Cloud Paweletz
    Aaron R. Thorner
    Kai W. Wucherpfennig
    Jun Qi
    Myles Brown
    Piotr Sicinski
    Thomas O. McDonald
    David Pellman
    Franziska Michor
    Kornelia Polyak
    Nature Communications, 11
  • [37] Mechanisms of Resistance to CDK4/6 Inhibitors in Hormone Receptor-Positive (HR +) Breast Cancer: Spotlight on Convergent CDK6 Upregulation and Immune Signaling
    Jamie O. Brett
    Paige E. Herman
    Erica L. Mayer
    Aditya Bardia
    Seth A. Wander
    Current Breast Cancer Reports, 2022, 14 : 222 - 232
  • [38] CDK4/6 inhibition in early and metastatic breast cancer: A review
    de Groot, A. F.
    Kuijpers, C. J.
    Kroep, J. R.
    CANCER TREATMENT REVIEWS, 2017, 60 : 130 - 138
  • [39] Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
    Ge, Jennifer Y.
    Shu, Shaokun
    Kwon, Mijung
    Jovanovi, Bojana
    Murphy, Katherine
    Gulvady, Anushree
    Fassl, Anne
    Trinh, Anne
    Kuang, Yanan
    Heavey, Grace A.
    Luoma, Adrienne
    Paweletz, Cloud
    Thorner, Aaron R.
    Wucherpfennig, Kai W.
    Qi, Jun
    Brown, Myles
    Sicinski, Piotr
    McDonald, Thomas O.
    Pellman, David
    Michor, Franziska
    Polyak, Kornelia
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [40] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    CANCER GENE THERAPY, 2022, 29 (06) : 859 - 869
12345